Carter Charles Ross bought OVID
July 6, 2026 · Form 4 insider transaction
Carter Charles Ross bought 50,000 shares of Ovid Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$0.00
Total value
N/A
InsiderCarter Charles Ross
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 6, 2026
Filing dateJuly 8, 2026
Shares owned after94,375
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit ("RSU") award. The RSUs will vest in two equal annual installments commencing on July 6, 2027, subject to the Reporting Person's continuous service through each such vesting date.; Each RSU represents a contingent right to receive one share of Common Stock.